e-learning
resources
ERJ
2012
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment
Martínez-García M-A., Campos-Rodríguez F., Soler-Cataluña J-J., Catalán-Serra P., Román-Sánchez P., Montserrat J-M.
Source:
Eur Respir J 2012; 39: 906-912
Journal Issue:
April
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Martínez-García M-A., Campos-Rodríguez F., Soler-Cataluña J-J., Catalán-Serra P., Román-Sánchez P., Montserrat J-M.. Increased incidence of nonfatal cardiovascular events in stroke patients with sleep apnoea: effect of CPAP treatment. Eur Respir J 2012; 39: 906-912
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Static lung volumes and spirometry measurements
Panel discussion: The role of pharmacotherapy connected to OSA pathophysiological traits
Expert interview ERS guideline on non-CPAP therapies in obstructive sleep apnoea
Related content which might interest you:
Early treatment of obstructive apnoea and stroke outcome: a randomised controlled trial
Source: Eur Respir J 2011; 37: 1128-1136
Year: 2011
Mortality in sleep apnoea syndrome: a review of the evidence
Source: Eur Respir Rev 2007; 16: 203-210
Year: 2007
Should obstructive sleep apnoea be treated regarding the related cardiovascular risk in non sleepy patients?
Source: Annual Congress 2006 - Obstructive sleep apnoea and cardiovascular diseases
Year: 2006
Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years
Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea
Year: 2006
CPAP in the elderly with non-severe obstructive sleep apnea: effect on cardiovascular events and somnolence.
Source: International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Year: 2017
Sleep apnoea and systemic hypertension
Source: Eur Respir Mon 2010; 50: 150-173
Year: 2010
Resting electrocardiographic (EKG) changes, the cardiovascular risk factors and the effect of CPAP (continuous positive airways pressure) therapy on high blood pressure evolution in patients with sleep apnoea syndrome
Source: Eur Respir J 2005; 26: Suppl. 49, 564s
Year: 2005
Impact of obstructive sleep apnea and CPAP treatment on mortality and cardio and cerebrovascular consequences in men of the general population after 20 years of follow-up.
Source: Virtual Congress 2020 – From pathophysiology to clinical consequences of sleep and breathing disorders
Year: 2020
Pulse-rate variability during sleep studies predicts stroke risk in patients with obstructive sleep apnea
Source: Virtual Congress 2021 – From pathophysiology to different diagnostic modalities in sleep disordered breathing
Year: 2021
SAHS and stroke. CPAP compliance and new stroke events
Source: Annual Congress 2011 - Obstructive sleep apnoea: the heart and the brain
Year: 2011
Treatment of obstructive sleep apnoea with nasal continuous positive airway pressure in stroke
Source: Eur Respir J 2001; 18: 623-629
Year: 2001
Cardiovascular morbidity and mortality in patients with obstructive sleep apnea - a prospective study
Source: Annual Congress 2005 - What should we know about our SAS patients
Year: 2005
Sleep apnoea and post-stroke vascular events: is it only due to poor continuous positive airway pressure use?
Source: Eur Respir J 2012; 40: 513
Year: 2012
Sleep apnoea and post-stroke vascular events: is it only due to poor continuous positive airway pressure use?
Source: Eur Respir J 2012; 40: 514
Year: 2012
CPAP and measures of cardiovascular risk in males with OSAS
Source: Eur Respir J 2008; 32: 1488-1496
Year: 2008
Continuous positive airway pressure does not reduce blood pressure in nonsleepy hypertensive OSA patients
Source: Eur Respir J 2006; 27: 1229-1235
Year: 2006
Nasal continuous positive airway pressure in stroke patients with sleep apnoea: a randomized treatment study
Source: Eur Respir J 2001; 18: 630-634
Year: 2001
Association between oximetry-derived pulse-rate variability and stroke risk in patients with obstructive sleep apnoea
Source: Sleep and Breathing Conference 2021
Year: 2021
CPAP can decrease fatal and non-fatal cardiovascular events in OSAH
Source: ISSN=ISSN 1810-6838, ISBN=, page=266
Year: 2006
Effect of compliance to continuous positive airway pressure treatment on serum cardiovascular risk factors in patients with obstructive sleep apnea-hypopnea syndrome
Source: Eur Respir J 2007; 30: Suppl. 51, 320s
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept